Characteristics | Pan-susceptible TB throughouta n = 1609(%) | Any acquired drug resistant TBb | Acquired MDR-TB vs. Pan-susceptible TB throughout | Acquired Non- MDR-TB vs. Pan-susceptible TB throughout | |||
---|---|---|---|---|---|---|---|
 | MDR-TBc n = 17(%) | Non-MDR-TBd n = 45(%) | OR (95 % CI)e | P value | OR(95 % CI) | P value | |
Age(years) | Â | Â | Â | Â | Â | Â | Â |
 <40 | 756(47.0) | 1(5.9) | 19(42.2) | Reference |  | Reference |  |
 40–59 | 560(34.8) | 13(76.5) | 20(44.5) | 17.5(2.3–134.6) | <0.001 | 1.4(0.8–2.7) | 0.278 |
 ≥60 | 293(18.2) | 3(17.6) | 6(13.3) | 7.7(0.8–74.7) | 0.07g | 0.8(0.3–2.1) | 0.665 |
Gender | Â | Â | Â | Â | Â | Â | Â |
 Male | 1160(72.1) | 14(82.4) | 35(77.8) | Reference |  | Reference |  |
 Female | 449(27.9) | 3(17.6) | 10(22.2) | 0.6(0.2–1.9) | 0.427g | 0.7 (0.4–1.5) | 0.401 |
BMIf (Kg/m2) | Â | Â | Â | Â | Â | Â | Â |
 BMI < 18.5 | 620(38.5) | 3(17.6) | 18(40.0) | Reference |  | Reference |  |
 BMI ≥ 18.5 | 989(61.5) | 14(82.4) | 27(60.0) | 2.9(0.8–10.2) | 0.078 | 0.9(0.5–1.7) | 0.842 |
Treatment history | Â | Â | Â | Â | Â | Â | Â |
 New | 1407(87.4) | 11(64.7) | 38(84.4) | Reference |  | Reference |  |
 Previously treated | 202(12.6) | 6(35.3) | 7(15.6) | 3.8(1.4–10.4) | 0.015g | 1.3(0.6–2.9) | 0.550 |